Drug Shortage Report for ADMELOG SOLOSTAR
Report ID | 166492 |
Drug Identification Number | 02469871 |
Brand name | ADMELOG SOLOSTAR |
Common or Proper name | ADMELOG SOLOSTAR |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN LISPRO |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5 pens/box |
ATC code | A10AB |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-08-26 |
Actual start date | 2022-08-24 |
Estimated end date | 2022-09-23 |
Actual end date | 2022-09-21 |
Shortage status | Resolved |
Updated date | 2022-09-22 |
Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-09-22 | English | Compare |
v9 | 2022-09-21 | French | Compare |
v8 | 2022-09-21 | English | Compare |
v7 | 2022-09-19 | French | Compare |
v6 | 2022-09-19 | English | Compare |
v5 | 2022-08-25 | English | Compare |
v4 | 2022-08-24 | French | Compare |
v3 | 2022-08-24 | English | Compare |
v2 | 2022-08-11 | French | Compare |
v1 | 2022-08-11 | English | Compare |
Showing 1 to 10 of 10